ask="17.50"
ask_size="500"
average_daily_volume="1405100"
bid="17.04"
bid_size="1000"
book_value="10.76"
change="-0.10"
change_from_200_day_moving_average="-1.83"
change_from_50_day_moving_average="0.87"
change_from_52_week_high="-22.47"
change_From_52_week_low="2.12"
change_in_percent="-0.60%"
close="17.27"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="0.88"
ebitda="143.80M"
eps_estimate_current_year="0.99"
eps_estimate_next_quarter="0.27"
eps_estimate_next_year="1.07"
ex_dividend_date="7/1/2009"
float_shares="60304000"
high="17.46"
high_52_weeks="39.74"
last_trade_date="2/16/2017"
last_trade_price="17.27"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="17.03"
low_52_weeks="15.15"
market_capitalization="1.18B"
moving_average_200_day="19.10"
moving_average_50_day="16.40"
name="Myriad Genetics
Inc."
notes="N/A"
one_year_target_price="19.09"
open="17.37"
pe_ratio="19.51"
peg_ratio="-5.62"
percent_change_from_200_day_moving_average="-9.58%"
percent_change_from_50_day_moving_average="+5.33%"
percent_change_from_52_week_high="-56.54%"
percent_change_from_52_week_low="+13.99%"
previous_close="17.38"
price_eps_estimate_current_year="17.44"
price_eps_Estimate_next_year="16.14"
price_per_book="1.61"
price_per_sales="1.58"
revenue="750.90M"
shares_outstanding="68091000"
short_ratio="21.26"
stock_exchange="NMS"
symbol="MYGN"
volume="1573052"
weeks_range_52="15.15 - 39.74"
